Diagnostic value of the abnormal digital rectal examination in the modern MRI-based prostate cancer diagnostic pathway
Journal of Clinical Urology · 2024-07 · 17 (4) · 412-418
DOI: 10.1177/20514158221091402 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Urology, online erschienen am 27.04.2022. Verfasst von Wasiq Sajjad und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, University of Cambridge, UK. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Department of Health.
Abstract (Originalsprache)
Objective
Currently the National Institute for Health and Care Excellence (NICE) recommends an abnormal digital rectal examination (DRE) as a standalone referral criterion for suspected prostate cancer. Unlike referrals for a raised prostate-specific antigen (PSA) which are triaged directly to magnetic resonance imaging (MRI), an abnormal DRE requires re-examination in a secondary clinic first. Here, we investigated the ongoing value of the abnormal DRE as a referral criterion.
Methods
This study is a retrospective review of patients referred to secondary care for suspected prostate cancer based on an abnormal DRE over a 15-month period at a single UK hospital ( n = 158). Age, PSA, primary and repeat DRE findings and eventual diagnosis were collated.
Results
A concurrent raised PSA was present in 65/158 (41%). Concordance between primary and secondary care DRE was only 72/158 (46%). The overall and significant cancer detection rate was 26/158 (16%) and 22/158 (14%), respectively. Among men with a concurrent raised PSA, 19/65 (29%) had significant cancer found, whereas with an abnormal primary care DRE and normal PSA ( n = 93), only 3/93 (3%) had a significant cancer. Mandating a PSA before referral for an abnormal DRE would have redirected 65/158 (41%) of men to MRI first, negating the need for a repeat DRE ( p < 0.0001). This finding was recapitulated in a second prospective validation cohort ( n = 30) with 9/30 (30%) redirected to MRI first.
Conclusions
This is one of the first studies to investigate the value of the DRE in contemporary practice. We propose that PSA is used to triage men with an abnormal DRE to MRI without needing a repeat DRE. If the PSA is normal, the diagnostic yield is low but may still warrant a repeat DRE to assess the need for further investigations. Additional multi-centre studies are required to further validate our findings. Level of evidence: 4
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Clinical Medicine, University of Cambridge, UK.
- Department of Urology, Cambridge University Hospitals Trust, UK.
- Division of Urology, Department of Surgery, University of Cambridge, UK.
- Cambridge Urology Translational Research and Clinical Trials Office, Cambridge Biomedical Campus, University of Cambridge & Cambride University Hospital, Cambridge, UK.
ORCID-Profile: Wasiq Sajjad, Vincent J Gnanapragasam
Förderung
- Department of Health
Zitieren
APA
Sajjad, W., Thankappannair, V., Shah, S., Ahmed, A., Saeb-Parsy, K., Kastner, C., Lamb, B., & Gnanapragasam, V. J. (2024). Diagnostic value of the abnormal digital rectal examination in the modern MRI-based prostate cancer diagnostic pathway. Journal of Clinical Urology, 17(4), 412-418. https://doi.org/10.1177/20514158221091402
Vancouver
Sajjad W, Thankappannair V, Shah S, Ahmed A, Saeb-Parsy K, Kastner C, et al. Diagnostic value of the abnormal digital rectal examination in the modern MRI-based prostate cancer diagnostic pathway. Journal of Clinical Urology. 2024;17(4):412-418. doi:10.1177/20514158221091402
BibTeX
@article{Sajjad2024,
author = {Sajjad, Wasiq and Thankappannair, Vineetha and Shah, Syed and Ahmed, Adham and Saeb-Parsy, Kasra and Kastner, Christof and Lamb, Benjamin and Gnanapragasam, Vincent J},
title = {Diagnostic value of the abnormal digital rectal examination in the modern MRI-based prostate cancer diagnostic pathway},
journal = {Journal of Clinical Urology},
year = {2024},
volume = {17},
number = {4},
pages = {412--418},
doi = {10.1177/20514158221091402}
}
EUVIMED